Listed

Adaptimmune Therapeutics PLC: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 8, 2016 and accepted by EDGAR at Aug 8, 2016, 11:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$328.0kus-gaap:SalesRevenueNet
Revenue6 months2016-01-01 to 2016-06-30$3.2mus-gaap:SalesRevenueNet
Research and development3 months2016-04-01 to 2016-06-30$16.2mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-01-01 to 2016-06-30$30.1mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-04-01 to 2016-06-30−$22.7mus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$39.5mus-gaap:OperatingIncomeLoss
Income tax3 months2016-04-01 to 2016-06-30$293.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-01-01 to 2016-06-30$352.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-04-01 to 2016-06-30−$22.1mus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$37.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30−$0.05us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30−$0.09us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure6 months2016-01-01 to 2016-06-30$2.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-06-30$150.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-06-30$218.2mus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$239.6mus-gaap:Assets
Current liabilitiesAt period end2016-06-30$20.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$42.6mus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30$197.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-16-137807. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.